Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • giuliano stirparo
    Junior Member
    • Nov 2011
    • 6

    glm edgeR issue

    Hi everybody
    I just performed a time series analysis on edgeR and I have a question.
    This is my data frame for the condition and time:
    sample condition time
    1 sample1 Placebo 1h
    2 sample2 Placebo 1h
    3 sample3 Placebo 2h
    4 sample4 Placebo 2h
    3 sample5 Placebo 4h
    4 sample6 Placebo 4h
    5 sample7 Drug 1h
    6 sample8 Drug 1h
    7 sample9 Drug 2h
    8 sample10 Drug 2h
    9 sample11 Drug 4h
    10 sample12 Drug 4h

    and my script to test interaction

    design<-model.matrix(~condition*time,data=meta)
    y<-DGEList(counts=countTable)
    y<-calcNormFactors(y,method="TMM")
    y<-estimateGLMCommonDisp(y,design)
    y<-estimateGLMTrendedDisp(y,design)
    y<-estimateGLMTagwiseDisp(y,design)
    fit<-glmFit(y,design)
    colnames(design)
    "(intercept)" "conditionDrug" "time2h" "time4h" "conditionDrug:time2h" "conditionDrug:time4h"
    lrt<-glmLRT(fit,coef=6)
    In this case with coef=6 I am able to detect the genes that respond differently to the drug, relative to placebo at 4h.
    But same gene that are modulated are not expressed either in placebo 4h and Drug 4h!!!
    Example(matrix of countTable)
    ID Placebo-1h Placebo-1h Placebo-2h Placebo-2h Placebo-4h Placebo-4h Drug-1h Drug-1h Drug-2h Drug-2h Drug-4h Drug-4h
    ENSMUSG000000xxxx 0 5 4 0 0 0 0 3 0 1 0 0
    And here the different comparison
    ID logFC logCPM LR PValue
    "ENSMUSG000000xxxx" -4.36 0.14 6.48 0.01 Placebo4-h
    "ENSMUSG000000xxxx" -2.19 0.14 1.21 0.27 Drug-4h
    "ENSMUSG000000xxxx" 2.16 0.14 100.14 1.41e-23 Contrast(Placebo-4h/Drug-4h)
    As you can see in the contrast Placebo-4h and Drug-4h I have a logFC of 2.16(that is the difference between Placebo-1h/Placebo-4h and Drug-1h/Drug-4h) and a PValue of 1.41e-23!!But I have no reads on this gene!
    How is possible?
    Could you help me to understand if I made same mistake in the analysis?

    Thank you

    Giuliano
  • Gordon Smyth
    Member
    • Apr 2011
    • 91

    #2
    No this isn't possible, so you have presumably made a mistake.

    The edgeR User's Guide asks you to send questions to the Bioconductor mailing list. If you write to that list, someone will help diagnose your problem.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    210 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...